Endometrial carcinoma - Gynecology

What is Endometrial Carcinoma?

Endometrial carcinoma is a type of cancer that originates from the lining of the uterus, known as the endometrium. It is the most common type of uterine cancer and primarily affects postmenopausal women. This malignancy usually presents with abnormal uterine bleeding, which often prompts early medical consultation and diagnosis.

Risk Factors

Several factors can increase the risk of developing endometrial carcinoma. These include prolonged exposure to estrogen without the counterbalancing effect of progesterone, which can happen in cases of hormone replacement therapy, obesity, early menarche, and late menopause. Additionally, conditions like polycystic ovary syndrome (PCOS), diabetes, and hypertension are also associated with elevated risk.

Symptoms

The most common symptom is abnormal uterine bleeding, especially in postmenopausal women. Other symptoms can include pelvic pain, pain during intercourse, and unexplained weight loss. In premenopausal women, symptoms can manifest as irregular menstrual cycles or heavy menstrual bleeding.

Diagnosis

Diagnosis typically begins with a thorough medical history and physical examination. A transvaginal ultrasound is often the first imaging test performed to evaluate the thickness of the endometrium. If the endometrium appears thickened, an endometrial biopsy is usually recommended. Other diagnostic tools include hysteroscopy and dilation and curettage (D&C).

Treatment Options

Treatment depends on the stage and grade of the cancer, as well as the patient's overall health and preferences. The primary treatment for endometrial carcinoma is surgical removal of the uterus, known as a hysterectomy. This may be accompanied by the removal of the ovaries and fallopian tubes (bilateral salpingo-oophorectomy). In some cases, lymph node dissection may be required. Additional treatments may include radiation therapy, chemotherapy, and hormone therapy.

Prognosis

The prognosis for endometrial carcinoma is generally favorable, especially when diagnosed early. The 5-year survival rate for early-stage endometrial cancer is quite high, often exceeding 90%. However, the prognosis worsens significantly with advanced stages of the disease.

Prevention and Monitoring

Preventive measures include maintaining a healthy weight, managing chronic conditions like diabetes and hypertension, and considering the risks and benefits of hormone replacement therapy. Regular gynecological check-ups and prompt attention to abnormal uterine bleeding can aid in early detection and treatment.

Conclusion

Endometrial carcinoma is a significant concern in gynecology, especially for postmenopausal women. Understanding the risk factors, symptoms, and treatment options can help in early diagnosis and effective management of this disease. Regular medical check-ups and awareness of abnormal symptoms are crucial for early detection and improved prognosis.



Relevant Publications

Partnered Content Networks

Relevant Topics